Article

AJMC in the Press, August 26, 2016

Author(s):

A review of our peer-reviewed research, in the healthcare and mainstream press.

Studies from the current issue of The American Journal of Managed Care have been cited frequently this week.

New research from the CVS Health Research Institute was one of the most-cited articles this week. The study found that interventions to keep patients with common chronic conditions on their medication are very cost effective, especially if those interventions target patients who take 3 or more medications. Payers can save between $38 million and $63 million per 100,000 members by focusing on these patient populations. Multiple outlets cited the study, including The Pharmacist, the official publication of the American Pharmacist Association.

In addition, the Center for Infectious Disease Research and Policy at the University of Minnesota discussed an article by CDC authors, who found that more than three-fourths of adults diagnosed as having bronchitis receive an antibiotic, even though antibiotics are not indicated for this condition.

Related Videos
Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council
Dan Nardi
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Jawad Haider Butt, MD, PhD
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
JC Scott, CEO and president, PCMA
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Adam Colburn, JD, vice president for congressional affairs, AMCP
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo